Impact of minimal residual disease prior to conditioning and chimerism after BMT in childhood acute lymphoblastic leukaemia.

被引：0
|
作者：
Hancock, J
Goulden, N
Oakhill, A
Ferris, V
Moppett, J
Burke, A
Garland, R
Groves, S
Cornish, J
Pamphilon, D
Steward, C
机构：
[1] Univ Bristol, Bristol BS8 1TH, Avon, England
[2] Royal Hosp Sick Children, Bristol BS2 8BJ, Avon, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2818
引用
收藏
页码：673A / 673A
页数：1
相关论文
共 50 条
  • [1] Minimal residual disease prior to stem cell transplant for childhood acute lymphoblastic leukaemia
    Goulden, N
    Bader, P
    Van der Velden, V
    Moppett, J
    Schilham, M
    Masden, HO
    Krejci, O
    Kreyenberg, H
    Lankester, A
    Révész, T
    Klingebiel, T
    Van Dongen, J
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 122 (01) : 24 - 29
  • [2] Minimal residual disease detection by interphase FISH in hyperdiploid acute lymphoblastic leukaemia.
    Kasprzyk, A
    SeckerWalker, LM
    JOURNAL OF MEDICAL GENETICS, 1997, 34 : 228 - 228
  • [3] Durability of minimal residual disease prior to BMT: can we improve on its prognostic value for patients with childhood acute lymphoblastic leukaemia?
    Tan, P. L.
    Villegas, M.
    Chan, Y. H.
    Yeaoh, A.
    Quah, T. C.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S189 - S189
  • [4] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
    van Dongen, JJM
    Seriu, T
    Panzer-Grümayer, ER
    Biondi, A
    Pongers-Willemse, MJ
    Corral, L
    Stolz, F
    Schrappe, M
    Masera, G
    Kamps, WA
    Gadner, H
    van Wering, ER
    Ludwig, WD
    Basso, G
    de Bruijn, MAC
    Cazzaniga, G
    Hettinger, A
    van der Does-van den Berg, A
    Hop, WCJ
    Riehm, H
    Bartram, CR
    LANCET, 1998, 352 (9142): : 1731 - 1738
  • [5] Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
    Matsumura, T
    Kami, M
    Saito, T
    Sakamaki, H
    Hirai, H
    LANCET, 1999, 353 (9154): : 752 - 752
  • [6] Minimal residual disease (MRD) assessment after allogeneic BMT for childhood acute lymphoblastic leukaemia (ALL) allows early prediction of relapse.
    Knechtli, C
    Goulden, N
    Harris, E
    Hancock, J
    Jones, C
    Grandage, V
    Garland, R
    Potter, M
    Cornish, J
    Pamphilon, D
    Steward, C
    Oakhill, A
    BLOOD, 1997, 90 (10) : 2431 - 2431
  • [7] The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia
    Moppett, J
    Burke, GAA
    Steward, CG
    Oakhill, A
    Goulden, NJ
    JOURNAL OF CLINICAL PATHOLOGY, 2003, 56 (04) : 249 - 253
  • [8] Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
    Eckert, C
    Biondi, A
    Seeger, K
    Cazzaniga, G
    Hartmann, R
    Beyermann, B
    Pogodda, M
    Proba, J
    Henze, G
    LANCET, 2001, 358 (9289): : 1239 - 1241
  • [9] Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia
    Goulden, N
    Oakhill, A
    Steward, C
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (02) : 275 - 281
  • [10] Intensified conditioning for children undergoing BMT for first bone marrow relapse of acute lymphoblastic leukaemia.
    Moppett, J
    Hancock, J
    Knechtli, CJC
    Oakhill, A
    Goulden, NJ
    BLOOD, 2004, 104 (11) : 376B - 377B
12345